vs
Side-by-side financial comparison of BLACKBOXSTOCKS INC. (BLBX) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $628.4K, roughly 1.9× BLACKBOXSTOCKS INC.). BLACKBOXSTOCKS INC. runs the higher net margin — -255.8% vs -858.5%, a 602.8% gap on every dollar of revenue. On growth, BLACKBOXSTOCKS INC. posted the faster year-over-year revenue change (7.4% vs 3.3%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -1.6%).
Blackboxstocks Inc. is a US-based fintech firm operating a subscription trading analytics platform for retail and active traders. It provides real-time market data, trade signals, analytical tools and social trading features for equity, options and digital asset markets, making institutional-grade trading resources accessible to individual users.
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
BLBX vs LUCD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $628.4K | $1.2M |
| Net Profit | $-1.6M | $-10.4M |
| Gross Margin | 60.6% | — |
| Operating Margin | -248.0% | -971.0% |
| Net Margin | -255.8% | -858.5% |
| Revenue YoY | 7.4% | 3.3% |
| Net Profit YoY | -69.4% | 16.0% |
| EPS (diluted) | — | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $628.4K | — | ||
| Q3 25 | $697.0K | $1.2M | ||
| Q2 25 | $518.8K | $1.2M | ||
| Q1 25 | $587.1K | $828.0K | ||
| Q4 24 | $585.0K | $1.2M | ||
| Q3 24 | $647.8K | $1.2M | ||
| Q2 24 | $684.7K | $976.0K | ||
| Q1 24 | $649.4K | $1.0M |
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-720.6K | $-10.4M | ||
| Q2 25 | $-1.3M | $-4.4M | ||
| Q1 25 | $-829.1K | $-26.9M | ||
| Q4 24 | $-948.7K | $-11.5M | ||
| Q3 24 | $-780.8K | $-12.4M | ||
| Q2 24 | $-877.9K | $-11.0M | ||
| Q1 24 | $-863.7K | $-10.6M |
| Q4 25 | 60.6% | — | ||
| Q3 25 | 53.7% | — | ||
| Q2 25 | 32.2% | — | ||
| Q1 25 | 41.6% | — | ||
| Q4 24 | 26.5% | — | ||
| Q3 24 | 54.7% | — | ||
| Q2 24 | 48.0% | — | ||
| Q1 24 | 44.9% | — |
| Q4 25 | -248.0% | — | ||
| Q3 25 | -63.0% | -971.0% | ||
| Q2 25 | -220.4% | -978.8% | ||
| Q1 25 | -151.2% | -1508.1% | ||
| Q4 24 | -151.5% | -1033.8% | ||
| Q3 24 | -113.3% | -997.8% | ||
| Q2 24 | -120.5% | -1146.7% | ||
| Q1 24 | -133.0% | -1078.1% |
| Q4 25 | -255.8% | — | ||
| Q3 25 | -103.4% | -858.5% | ||
| Q2 25 | -244.7% | -381.7% | ||
| Q1 25 | -141.2% | -3249.8% | ||
| Q4 24 | -162.2% | -964.2% | ||
| Q3 24 | -120.5% | -1055.5% | ||
| Q2 24 | -128.2% | -1127.6% | ||
| Q1 24 | -133.0% | -1060.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.10 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.52 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.7M | $25.8M |
| Total Assets | $8.7M | $53.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $47.3M | ||
| Q2 25 | — | $31.1M | ||
| Q1 25 | — | $25.2M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | $60.9K | $14.5M | ||
| Q2 24 | $1.1M | $24.9M | ||
| Q1 24 | $115.0K | $24.8M |
| Q4 25 | $5.7M | — | ||
| Q3 25 | $4.8M | $25.8M | ||
| Q2 25 | $3.6M | $7.9M | ||
| Q1 25 | $4.7M | $-5.4M | ||
| Q4 24 | $5.4M | $5.4M | ||
| Q3 24 | $6.3M | $6.3M | ||
| Q2 24 | $5.8M | $16.0M | ||
| Q1 24 | $6.5M | $11.9M |
| Q4 25 | $8.7M | — | ||
| Q3 25 | $8.8M | $53.2M | ||
| Q2 25 | $9.9M | $38.7M | ||
| Q1 25 | $10.2M | $32.8M | ||
| Q4 24 | $9.9M | $30.7M | ||
| Q3 24 | $10.0M | $22.6M | ||
| Q2 24 | $9.9M | $34.1M | ||
| Q1 24 | $9.0M | $32.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-510.4K | $-10.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-510.4K | — | ||
| Q3 25 | $-955.9K | $-10.9M | ||
| Q2 25 | $-1.1M | $-10.5M | ||
| Q1 25 | $-643.7K | $-12.5M | ||
| Q4 24 | $-24.4K | $-9.9M | ||
| Q3 24 | $5.8K | $-10.2M | ||
| Q2 24 | $-333.4K | $-11.5M | ||
| Q1 24 | $-353.8K | $-12.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
